FilingSEC EDGAR8-K
Jasper Therapeutics Receives Nasdaq Deficiency Notice Regarding Stockholders' Equity
· SEC accepted
StageDeficiency Notice
Filing content
Jasper Therapeutics received a notice from Nasdaq for failing to meet the $2.5 million stockholders' equity requirement and plans to submit a compliance plan by October 5.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…